Year

2022

Status

Active

Team

 

Field

Complement-mediated diseases

Location

United Kingdom

Fund

BGV IV

Complement Therapeutics

Complement Therapeutics is a spin-out from The University of Manchester. Its founders have international reputations and world-leading Complement System expertise.